An unusually high number of people presenting with COVID-19 disease in the UK are developing diabetic ketoacidosis, hyperosmolar hyperglycaemic state, or a combination of both, which require high doses of insulin. Guidance on the management of DKA from the UK’s National Diabetes Inpatient COVID-19 Response Group has included a back-up option of using subcutaneous insulin ...
Unusually high rates of DKA seen in COVID-19
By Mardi Chapman
20 May 2020